Hunter College of City University of New York
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hunter College of City University of New York sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).
Hunter College of City University of New York: 29 sponsored US clinical trials, 5 recruiting.
Hunter College of City University of New York sponsors 29 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 21 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Substance Use, with 4 trials.
Top-decile sponsor footprint
Hunter College of City University of New York ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
29 total, page 1 of 1
A Palliative Care Model Impact on Knowledge and Attitudes
NCT06860932
Task Specific Training for Advanced Multiple Sclerosis
NCT06506929
Eccentric Exercise and Fatigue in Multiple Sclerosis
NCT06505421
Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
NCT06307977
Effect of Cooling on Balance Performance in Multiple Sclerosis
NCT06094855
Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples
NCT05000866
Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity
NCT07538063
Effect of Acetominophen an Gait Fatigue in Multiple Sclerosis
NCT07440446
Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults
NCT06126107
Korean Translation and Validation of the K-HEPI in NYC
NCT05544578
Effects of Therapeutic Mobile Game on Anxiety
NCT05240794
Nurses Taking On Readiness Measures - Mercer County, New Jersey
NCT05455580
Empowerment Self-Defense Training for the Prevention of Victimization of Transgender Women
NCT04934189
COVID-19 Knowledge, Attitudes, Practices and Perceived Risk: Cross Sectional Mixed Methods
NCT07021716
Transcranial Direct Current Stimulation (tDCS) Augments the Effects of Gamified, Mobile Attention Bias Modification
NCT04348812
Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk
NCT03386110
Prevention and Risk: Treatment With a New Emphasis on Relationships
NCT03396367
Intervention INC: Interactive Nutrition Comics for Urban Minority Youth
NCT03165474
Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color
NCT03488914
Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers
NCT02200003
Addressing Substance Use Through CVCT
NCT03125915
Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
NCT02037594
Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings
NCT02390908
tDCS and Aphasia Treatment
NCT01922245
Multicomponent Intervention to Reduce Sexual Risk and Substance Use
NCT01880489
An Innovative HIV Prevention Intervention Using Social Networking Technology
NCT01381653
Intervention Targeting Substance Using Older Adults With HIV
NCT01305629
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
NCT01122186
Risk Reduction Intervention for Vulnerable Young Adult Males
NCT01118416
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Hunter College of City University of New York pipeline
5 recruiting of 29 indexed (17% open); 21 completed (72%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Substance Use (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hunter College of City University of New York: open-pipeline peers nationwide
Peers matched on 29 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Hunter College of City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 29 trials (± recruiting share)
- BeOne Medicines · 29 trials · 79% recruiting
- BioCryst Pharmaceuticals · 29 trials · 7% recruiting
- California Pacific Medical Center Research Institute · 29 trials · 10% recruiting
- Center for International Blood and Marrow Transplant Research · 29 trials · 24% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Ochsner Health System · 17% recruiting · 29 trials
- Baylor Research Institute · 17% recruiting · 180 trials
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Emory University · 17% recruiting · 1,208 trials
Related
What to do with this Hunter College of City University of New York page
29 registered trials is a research-attention snapshot, not an endorsement of Hunter College of City University of New York or any single study.
- 5 of Hunter College of City University of New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance Use is the condition Hunter College of City University of New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hunter College of City University of New York pipeline card: 29 registered trials from official public datasets.Report a data error.